Blog
About

0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Paving the path for invasion: The polyedric role of LASP1 in cancer.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although usually referred to as a structural actin-binding protein, LIM and SH3 domain-containing protein may actually be dynamically involved in the control of a wide spectrum of cellular processes, by virtue of its interaction with several molecular partners. Alongside being ubiquitously expressed in physiological conditions, LIM and SH3 domain-containing protein is overexpressed in a growing number of human cancers, in which it may actively contribute to their aggressiveness by promoting cell proliferation and migration. In view of the recent findings, implicating the protein in cancer progression, we discuss here the most relevant discoveries highlighting the role of this versatile protein in various human tumors. The correlation between LIM and SH3 domain-containing protein expression levels in cancer and the poor outcome and metastatic behavior of tumors denotes the clinical significance of this protein and hints its potential value as a new cancer prognostic or even diagnostic biomarker. This may be decisive not only to optimize existing pharmacological regimes but also to delineate novel, more efficacious therapeutic and/or preventive approaches.

          Related collections

          Author and article information

          Journal
          Tumour Biol.
          Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
          SAGE Publications
          1423-0380
          1010-4283
          Jun 2017
          : 39
          : 6
          Affiliations
          [1 ] 1 Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture (Pz), Italy.
          [2 ] 2 Center for Molecular and Translational Oncology, University of Parma, Parma, Italy.
          [3 ] 3 Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
          Article
          10.1177/1010428317705757
          28621232

          microRNA, Cancer cell migration, invasion, metastasis

          Comments

          Comment on this article